← Back to all trials
Active Not Recruiting
NCT07798999
Anodic Stimulation in Parkinson's Disease
Conditions: Parkinson Disease (PD)
Sex: All
Ages: 40 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 20
Sponsor: University of South Florida
Location: USF Health STC Department of Neurosurgery and Tampa General Hospital Tampa Florida
Summary
Randomized, double-blind, crossover design, interventional study to assess the differences between mixed cathodic/anodic, pure cathodic, and pure anodic stimulation with respect to efficacy, side effect thresholds, symptom control, and quality of life in Parkinson's Disease patients implanted with Boston Scientific Cartesia directional DBS leads in the bilateral STN.
Eligibility Criteria
Inclusion Criteria:
* Patients that are between the ages of 40-80 years of age.
* Patients diagnosed with Idiopathic Parkinson's Disease that are treated with bilateral STN DBS Boston Scientific Vercise Cartesia directional leads for at least 3 months.
* Patients whose DBS settings can be optimized to include anodic and cathodic stimulation.
Exclusion Criteria:
* Parkinson's Disease patients implanted with DBS leads outside of FDA labeling.
* Patients who are not chronically using anodic stimulation parameters.
Source: ClinicalTrials.gov (NCT07798999). StuddyBuddy aggregates publicly available trial information.
